[CGM] my dawn phenomenon barely changed and that surprised me
my dawn phenomenon barely changed and that surprised me. Not a hot take, just something I have not seen said plainly here.
Kept fingersticks alongside the sensor for two weeks to sanity-check it. Worth doing once.
Brought the whole CGM export to my appointment rather than one number. Entirely different conversation.
Assumed the weight endpoints from the obesity trials applied to my situation. They are different programmes.
I will update this if the picture changes rather than quietly leaving it up.
best — the order this archive was captured in
Continuous monitoring shows the shape: postprandial excursions, overnight behaviour and time in range. Two people with identical A1c can have very different distributions.
postprandial excursions are where most of the improvement shows up first
The diabetes and obesity programmes are separate, with different populations and different primary endpoints. Reading a result across from one to the other is not a comparison.
Identifying details redacted from the exported report above.
nothing here replaces the person managing your diabetes
What does time in range look like, not just the average?
CGM shows you the shape, A1c shows you the area
metformin and an incretin agonist are not in competition
Incretin-based agents stimulate insulin secretion in a glucose-dependent manner, which is why hypoglycaemia risk with them alone is low. Risk rises with agents that act independently of glycaemia.
Variability dropped before the average did, which was visible on the sensor and invisible on the lab result.